Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ · Healthcare
Regeneron Pharmaceuticals, Inc. Price to Book Ratio 2006–2026
Price to book (P/B) ratio for Regeneron Pharmaceuticals, Inc. (REGN): market cap divided by shareholder equity. As of March 31, 2026 it is 2.66.
From: 06/30/2010To: 03/31/2026
Stock Price
Book Value
Price to Book
Regeneron Pharmaceuticals Inc. Price to Book Ratio — FAQ
Regeneron Pharmaceuticals Inc. (REGN) price to book ratio over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see REGN's price to book ratio history?
The chart and table above show Regeneron Pharmaceuticals Inc.'s price to book ratio by year and by quarter, including the growth rate.